EXOZ experienced severe financial deterioration with cash reserves plummeting 69% to $3.0M while R&D expenses doubled and operating losses increased 64% to $9.7M.
The company is burning through cash at an alarming rate with only $3.0M remaining versus $9.7M a year ago, creating potential going concern issues. The doubling of R&D expenses to $3.7M combined with widening losses suggests EXOZ is in a critical phase of development that requires significant capital investment, but the rapid cash depletion timeline may force difficult financing decisions or operational changes soon.
EXOZ's financial position deteriorated dramatically across all key metrics, with cash and equivalents falling 69% to just $3.0M while R&D expenses nearly doubled to $3.7M, driving operating losses up 64% to $9.7M. Total assets shrunk 54% and stockholders' equity declined 67% to $3.4M, reflecting the company's cash burn and accumulated losses. Despite a 24% improvement in operating cash flow to -$6.5M and reduced capital expenditures, the overall picture signals a company in financial distress with limited runway to fund operations without additional capital.
R&D investment increased 98.4% — signals commitment to future product development, though near-term margin impact.
Cash declined 68.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Current assets declined 63.6% — monitor working capital adequacy and short-term liquidity.
Capex reduced 57.1% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Net income declined 56.3% — review whether driven by operations, interest costs, or non-recurring items.
Total assets contracted 54.2% — asset sales, write-downs, or balance sheet optimization underway.
Operating cash flow grew 23.6% — strong conversion of earnings to cash, healthy business fundamentals.
Current liabilities rose 17.5% — increased short-term obligations, watch current ratio.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →